Bridgewater, NJ. April 15, 2008. LabVantage today announced that it will be showcasing its SAPPHIRE™ Laboratory Information Management Suite, including its SAPPHIRE BioBanking Solution now with Integrative Analytics, at the 2008 Bio-IT World Conference & Expo, April 28th – 30th, and the 2008 Translational Research Symposium May 2nd, in Boston. LabVantage will also be exhibiting and supporting main track presentations at each event.

The SAPPHIRE BioBanking Solution with Integrative Analytics couples the best of enterprise biorepository management with the best of data integration and interactive analytics. Because today’s translational research is critically dependant on biospecimens for biological research, it requires a far more unified and large-scale software solution to manage and track these biological materials, as well as, the experiment, sample, and clinical data associated with them. By coupling biospecimen management with integrative analytics, organizations can not only more effectively operate their biorepositories, execute their protocols, and manage their samples, but also mine and analyze the data stored throughout their heterogeneous scientific and operational systems. The approach leverages configurable, modular driven products, rather than custom developed software or services, for workflow driven laboratory information management and automation, as well as, workflow driven integrative analytics that enable translational medicine.

LabVantage will feature ongoing demonstrations of its SAPPHIRE Suite and SAPPHIRE BioBanking Solution with Integrative Analytics at Bio-IT World Conference & Expo and the Translational Research Symposium. To download a pre-recorded webcast of the latter, go to

LabVantage is also supporting presentations by one of its pioneering research customers, the Multiple Myeloma Research Consortium (MMRC), at each of these conferences:

Leveraging Biorepositories and Correlative Clinical Data to Drive Translational Medicine
Tuesday, April 29th at 4:45PM
Bio-IT World Congress
Track 5: Clinical and Medical Informatics in the “Informatics Tools for Clinical Decision Support & Translational Medicine”
Biobanking: Enabling Translational Research
Friday, May 2nd at 2:30PM
Translational Research Symposium
Steven Young
Executive Director
Multiple Myeloma Research Consortium
Alicia Sable-Hunt
Edwards-Hunt Group LLC
Former Program Manager, Multiple Myeloma Research Consortium

Additionally, as a result of the break-through research and development enabled by the MMRC’s implementation of the SAPPHIRE BioBanking Solution, LabVantage and the MMRC are finalists for a Bio-IT World Best Practices Award in the Translational Medicine category. Awards are to be presented at the Bio-IT World Best Practices Awards Dinner the evening of April 29th.

Furthermore, the SAPPHIRE BioBanking Solution with Integrative Analytics is an entry in this year’s Bio-IT World Best-of-Show Awards – Knowledge Management & Collaboration Applications category. Finalist will be announced at the conference and winners announced at the awards event, Tuesday, April 29 at 6:00pm in the exhibit hall.

For more information about LabVantage’s SAPPHIRE Suite and its SAPPHIRE BioBanking Solution with Integrative Analytics, please visit us at the Bio-IT World Conference (booth #200), and the Translational Research Symposium.

About LabVantage. LabVantage Solutions, Inc., an innovative global provider of enterprise solutions tailored for leading laboratories, serves discovery, development, formulation, process research, raw material testing, and quality management laboratories across multiple industries. LabVantage’s SAPPHIRE, a zero-footprint laboratory information management suite, is tailored to manage an organization’s critical laboratory information across its worldwide R&D pipeline and manufacturing supply chain to optimize productivity and more effectively share knowledge. LabVantage is headquartered in Bridgewater, NJ, U.S.A. Further information about LabVantage and SAPPHIRE is available at

About the MMRC Tissue Bank
The MMRC Tissue Bank is the only resource of its kind that provides researchers with the critical mass of high-quality myeloma tissue samples and related biospecimens necessary to rapidly advance research and drug discovery efforts. Notably, all tissue accrued into the MMRC Tissue Bank is uniformly collected and stored in adherence with Good Laboratory Practices (GLP) standards and under the governance of more than 50 standard operating procedures. With more than 400 patient tissue samples accrued to date and ongoing accrual at sites nationwide, researchers for the first time have access to the critical mass of tissue necessary to support important genomic studies, robust pre-clinical validation efforts, and critical correlative analyses.

About the Multiple Myeloma Research Consortium (MMRC)
The Multiple Myeloma Research Consortium (MMRC) is a 509a3 non-profit organization that integrates leading academic institutions to accelerate drug development in multiple myeloma. It is comprised of the MMRC and 10 member institutions: Dana-Farber Cancer Institute, Emory University’s Winship Cancer Institute, Hackensack University Medical Center, H. Lee Moffitt Cancer Center & Research Institute, Mayo Clinic, Ohio State University, Roswell Park Cancer Institute, St. Vincent’s Comprehensive Cancer Center of Saint Vincent Catholic Medical Centers of New York, University Health Network (Princess Margaret Hospital), and University of Chicago.

The MMRC was founded in 2004 by Kathy Giusti, a myeloma patient, and with the help of the scientific community, as an optimal research model to rapidly address critical challenges in accelerating drug development and explore opportunities in the most promising areas of myeloma research—genomics, compound validation, and clinical trials. The MMRC is the only consortium to join academic institutions through membership agreements, customized IT systems, and an integrated tissue bank. For more information, please visit

LabVantage, SAPPHIRE and their respective logos are trademarks or registered trademarks of LabVantage Solutions, Inc. in the U.S, the European Community, and other countries around the world. All other product and service names mentioned are the trademarks of their respective companies.

Share This